| Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2 Y Tang, J Zhang, M Xiao, G Lu, J Li, Q Liu, Y Guo, J Gu Redox Biology 52, 102310, 2022 | 66 | 2022 |
| Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways J Wang, J Zhang, M Xiao, S Wang, J Wang, Y Guo, Y Tang, J Gu Cellular and Molecular Life Sciences 78, 3105-3125, 2021 | 62 | 2021 |
| Epigenetic regulation associated with sirtuin 1 in complications of diabetes mellitus J Wang, S Wang, J Wang, M Xiao, Y Guo, Y Tang, J Zhang, J Gu Frontiers in endocrinology 11, 598012, 2021 | 26 | 2021 |
| Regulatory mechanisms of Sesn2 and its role in multi-organ diseases S Wang, M Xiao, J Zhang, Y Guo, Y Tang, J Gu Pharmacological Research 164, 105331, 2021 | 23 | 2021 |
| Resveratrol and FGF1 synergistically ameliorates doxorubicin-induced cardiotoxicity via activation of SIRT1-NRF2 pathway G Lu, Q Liu, T Gao, J Li, J Zhang, O Chen, C Cao, M Mao, M Xiao, ... Nutrients 14 (19), 4017, 2022 | 21 | 2022 |
| Resveratrol attenuates high glucose-induced osteoblast dysfunction via AKT/GSK3β/FYN-mediated NRF2 activation Y Xuan, J Wang, X Zhang, J Li, Q Liu, G Lu, M Xiao, T Gao, Y Guo, C Cao, ... Frontiers in Pharmacology 13, 862618, 2022 | 21 | 2022 |
| Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway. Nutrients 2022, 14, 4017 G Lu, Q Liu, T Gao, J Li, J Zhang, O Chen, C Cao, M Mao, M Xiao, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 21* | 2022 |
| A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity M Xiao, Y Tang, G Lu, J Niu, J Li, Q Liu, Z Wang, Z Huang, Y Guo, T Gao, ... Redox Biology 49, 102219, 2022 | 18 | 2022 |
| Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway X Xu, Q Liu, J Li, M Xiao, T Gao, X Zhang, G Lu, J Wang, Y Guo, P Wen, ... Frontiers in Pharmacology 13, 940406, 2022 | 14 | 2022 |
| NRF2-related epigenetic modifications in cardiac and vascular complications of diabetes mellitus J Wang, M Xiao, J Wang, S Wang, J Zhang, Y Guo, Y Tang, J Gu Frontiers in Endocrinology 12, 598005, 2021 | 12 | 2021 |
| The role of fibroblast growth factor 21 in diabetic cardiovascular complications and related epigenetic mechanisms M Xiao, Y Tang, S Wang, J Wang, J Wang, Y Guo, J Zhang, J Gu Frontiers in Endocrinology 12, 598008, 2021 | 11 | 2021 |
| Integration of dietary nutrition and TRIB3 action into diabetes mellitus G Lu, J Li, T Gao, Q Liu, O Chen, X Zhang, M Xiao, Y Guo, J Wang, ... Nutrition Reviews, nuad056, 2023 | 8 | 2023 |
| Regulatory role of endogenous and exogenous fibroblast growth factor 1 in the cardiovascular system and related diseases M Xiao, Y Tang, G Lu, Y Guo, J Zhang, J Gu Pharmacological Research 169, 105596, 2021 | 5 | 2021 |
| SESN2-mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High Fat Diet-induced Obese Mice T Gao, J Wang, M Xiao, J Wang, S Wang, Y Tang, J Zhang, G Lu, H Guo, ... Antioxidants and Redox Signaling, 2023 | 4 | 2023 |
